Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.

Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietzsch; Peter A Maubach; Helmut Lambertz; Daniel Oruzio; Rudolf Schlag; Karin Weigang-Köhler; Ute Vehling-Kaiser; Manfred Schulze; Juergen Truckenbrodt; Mariele Goebeler; Johann Mittermüller; Daniel Bosse; Borika Szukics; Marc Grundeis; Thomas Zwingers; Clemens Giessen; Volker Heinemann

doi:10.1016/j.ejca.2010.09.022

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.

Ludwig Fischer von Weikersthal
, Andreas Schalhorn
, Martina Stauch
, Detlef Quietzsch
, Peter A Maubach
, Helmut Lambertz
, Daniel Oruzio
, Rudolf Schlag
, Karin Weigang-Köhler
, Ute Vehling-Kaiser
, Manfred Schulze
, Juergen Truckenbrodt
, Mariele Goebeler
, Johann Mittermüller
, Daniel Bosse
, Borika Szukics
, Marc Grundeis
, Thomas Zwingers
, Clemens Giessen
, Volker Heinemann

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

42 Citations (Web of Science)

Original language	English
Pages (from-to)	206-214
Journal	EUROPEAN JOURNAL OF CANCER
Volume	47
Issue number	2
DOIs	https://doi.org/10.1016/j.ejca.2010.09.022
Publication status	Published - 2011

Keywords

RANDOMIZED-TRIAL
2ND-LINE TREATMENT
FLUOROURACIL-LEUCOVORIN
COMBINATION
CHEMOTHERAPY
MULTICENTER
EFFICACY
THERAPY
FAILURE
BEVACIZUMAB

Access to Document

10.1016/j.ejca.2010.09.022

Cite this

Fischer von Weikersthal, L., Schalhorn, A., Stauch, M., Quietzsch, D., Maubach, P. A., Lambertz, H., Oruzio, D., Schlag, R., Weigang-Köhler, K., Vehling-Kaiser, U., Schulze, M., Truckenbrodt, J., Goebeler, M., Mittermüller, J., Bosse, D., Szukics, B., Grundeis, M., Zwingers, T., Giessen, C., & Heinemann, V. (2011). Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer. EUROPEAN JOURNAL OF CANCER , 47(2), 206-214. https://doi.org/10.1016/j.ejca.2010.09.022

Fischer von Weikersthal, Ludwig ; Schalhorn, Andreas ; Stauch, Martina et al. / Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer. In: EUROPEAN JOURNAL OF CANCER 2011 ; Vol. 47, No. 2. pp. 206-214.

@article{cec5d2a3c916420387e49acfcd7ddae3,

title = "Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.",

keywords = "RANDOMIZED-TRIAL, 2ND-LINE TREATMENT, FLUOROURACIL-LEUCOVORIN, COMBINATION, CHEMOTHERAPY, MULTICENTER, EFFICACY, THERAPY, FAILURE, BEVACIZUMAB",

author = "\{Fischer von Weikersthal\}, Ludwig and Andreas Schalhorn and Martina Stauch and Detlef Quietzsch and Maubach, \{Peter A\} and Helmut Lambertz and Daniel Oruzio and Rudolf Schlag and Karin Weigang-K{\"o}hler and Ute Vehling-Kaiser and Manfred Schulze and Juergen Truckenbrodt and Mariele Goebeler and Johann Mitterm{\"u}ller and Daniel Bosse and Borika Szukics and Marc Grundeis and Thomas Zwingers and Clemens Giessen and Volker Heinemann",

year = "2011",

doi = "10.1016/j.ejca.2010.09.022",

language = "English",

volume = "47",

pages = "206--214",

journal = "EUROPEAN JOURNAL OF CANCER ",

issn = "0959-8049",

publisher = "Elsevier ",

number = "2",

}

Fischer von Weikersthal, L, Schalhorn, A, Stauch, M, Quietzsch, D, Maubach, PA, Lambertz, H, Oruzio, D, Schlag, R, Weigang-Köhler, K, Vehling-Kaiser, U, Schulze, M, Truckenbrodt, J, Goebeler, M, Mittermüller, J, Bosse, D, Szukics, B, Grundeis, M, Zwingers, T, Giessen, C & Heinemann, V 2011, 'Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.', EUROPEAN JOURNAL OF CANCER , vol. 47, no. 2, pp. 206-214. https://doi.org/10.1016/j.ejca.2010.09.022

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer. / Fischer von Weikersthal, Ludwig; Schalhorn, Andreas; Stauch, Martina et al.
In: EUROPEAN JOURNAL OF CANCER , Vol. 47, No. 2, 2011, p. 206-214.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.

AU - Fischer von Weikersthal, Ludwig

AU - Schalhorn, Andreas

AU - Stauch, Martina

AU - Quietzsch, Detlef

AU - Maubach, Peter A

AU - Lambertz, Helmut

AU - Oruzio, Daniel

AU - Schlag, Rudolf

AU - Weigang-Köhler, Karin

AU - Vehling-Kaiser, Ute

AU - Schulze, Manfred

AU - Truckenbrodt, Juergen

AU - Goebeler, Mariele

AU - Mittermüller, Johann

AU - Bosse, Daniel

AU - Szukics, Borika

AU - Grundeis, Marc

AU - Zwingers, Thomas

AU - Giessen, Clemens

AU - Heinemann, Volker

PY - 2011

Y1 - 2011

KW - RANDOMIZED-TRIAL

KW - 2ND-LINE TREATMENT

KW - FLUOROURACIL-LEUCOVORIN

KW - COMBINATION

KW - CHEMOTHERAPY

KW - MULTICENTER

KW - EFFICACY

KW - THERAPY

KW - FAILURE

KW - BEVACIZUMAB

U2 - 10.1016/j.ejca.2010.09.022

DO - 10.1016/j.ejca.2010.09.022

M3 - Original Article

C2 - 20971632

SN - 0959-8049

VL - 47

SP - 206

EP - 214

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

IS - 2

ER -

Fischer von Weikersthal L, Schalhorn A, Stauch M, Quietzsch D, Maubach PA, Lambertz H et al. Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer. EUROPEAN JOURNAL OF CANCER . 2011;47(2):206-214. doi: 10.1016/j.ejca.2010.09.022